Targeting the untargetable: Oncolytic virotherapy for the cancer stem cell

被引：6

作者：

Liu, Ta-Chiang ^{[1
]}

Kirn, David ^{[1
]}

机构：

[1] Jennerex Biotherapeut Inc, San Francisco, CA 94105 USA

来源：

MOLECULAR THERAPY | 2007年 / 15卷 / 12期

关键词：

D O I：

10.1038/sj.mt.6300337

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：2060 / 2061

页数：2

共 14 条

[1] Opinion - The origin of the cancer stem cell: current controversies and new insights [J].

Bjerkvig, R ;

Tysnes, BB ;

Aboody, KS ;

Najbauer, J ;

Terzis, AJA .

NATURE REVIEWS CANCER, 2005, 5 (11) :899-904

[2] Opinion - Migrating cancer stem cells - an integrated concept of malignant tumour progression [J].

Brabletz, T ;

Jung, A ;

Spaderna, S ;

Hlubek, F ;

Kirchner, T .

NATURE REVIEWS CANCER, 2005, 5 (09) :744-749

[3] Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow [J].

Breitbach, Caroline J. ;

Paterson, Jennifer M. ;

Lemay, Chantal G. ;

Falls, Theresa J. ;

McGuire, Allison ;

Parato, Kelley A. ;

Stojdl, David F. ;

Daneshmand, Manijeh ;

Speth, Kelly ;

Kirn, David ;

McCart, J. Andrea ;

Atkins, Harold ;

Bell, John C. .

MOLECULAR THERAPY, 2007, 15 (09) :1686-1693

[4] Tumour stem cells and drug resistance [J].

Dean, M ;

Fojo, T ;

Bates, S .

NATURE REVIEWS CANCER, 2005, 5 (04) :275-284

[5] Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter [J].

Dingli, D ;

Peng, KW ;

Harvey, ME ;

Greipp, PR ;

O'Connor, MK ;

Cattaneo, R ;

Morris, JC ;

Russell, SJ .

BLOOD, 2004, 103 (05) :1641-1646

[6] Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/Low cells [J].

Eriksson, Minna ;

Guse, Kilian ;

Bauerschmitz, Gerd ;

Virkkunen, Pekka ;

Tarkkanen, Maija ;

Tanner, Minna ;

Hakkarainen, Tanja ;

Kanerva, Anna ;

Desmond, Renee A. ;

Pesonen, Sari ;

Hemminki, Akseli .

MOLECULAR THERAPY, 2007, 15 (12) :2088-2093

[7] An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy [J].

Heise, C ;

Hermiston, T ;

Johnson, L ;

Brooks, G ;

Sampson-Johannes, A ;

Williams, A ;

Hawkins, L ;

Kirn, D .

NATURE MEDICINE, 2000, 6 (10) :1134-1139

[8] Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death [J].

Jiang, Hong ;

Gomez-Manzano, Candelaria ;

Aoki, Hiroshi ;

Alonso, Marta M. ;

Kondo, Seiji ;

McCormick, Frank ;

Xu, Jing ;

Kondo, Yasuko ;

Bekele, B. Nebiyou ;

Colman, Howard ;

Lang, Frederick F. ;

Fueyo, Juan .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18) :1410-1414

[9] Mechanisms of disease - Cancer stem cells [J].

Jordan, Craig T. ;

Guzman, Monica L. ;

Noble, Mark .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1253-1261

[10] A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer [J].

Khuri, FR ;

Nemunaitis, J ;

Ganly, I ;

Arseneau, J ;

Tannock, IF ;

Romel, L ;

Gore, M ;

Ironside, J ;

MacDougall, RH ;

Heise, C ;

Randlev, B ;

Gillenwater, AM ;

Bruso, P ;

Kaye, SB ;

Hong, WK ;

Kirn, DH .

NATURE MEDICINE, 2000, 6 (08) :879-885

← 1 2 →